Polyclonal Rabbit anti‑Human TSPO / PBR Antibody (90‑170 aa, C‑terminal, WB) LS‑C385380
Polyclonal Rabbit anti‑Human TSPO / PBR Antibody (90‑170 aa, C‑terminal, WB) LS‑C385380
Antibody:
TSPO / PBR Rabbit anti-Human Polyclonal (90-170 aa, C-terminal) Antibody
Format:
Unconjugated, Unmodified
Overview
Antibody:
TSPO / PBR Rabbit anti-Human Polyclonal (90-170 aa, C-terminal) Antibody
Format:
Unconjugated, Unmodified
Specifications
Description
PBR antibody LS-C385380 is an unconjugated rabbit polyclonal antibody to human PBR (TSPO) (90-170 aa, C-terminal). Validated for ELISA and WB.
Target
Human TSPO / PBR
Synonyms
TSPO | BZRP | BPBS | IBP | MBR | MDRC | PBR | PBRS | PBS | PKBS | PTBR | Pk18 | Translocator protein | Translocator protein (18kDa)
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Immunogen
Synthesized peptide derived from human PBR
Epitope
90-170 aa, C-terminal
Specificity
PBR Polyclonal Antibody detects endogenous levels of PBR protein.
Applications
- Western blot (1:500 - 1:2000)
- ELISA (1:40000)
Presentation
PBS, 0.02% Sodium Azide, 50% Glycerol, 0.5% BSA
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Mouse, Human
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Human, Mouse, Rat
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human
Applications:
Western blot
Species:
Human, Mouse, Rat
Applications:
IHC, IHC - Paraffin, Western blot
Reactivity:
Rat
Range:
0.312-20 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/5/2025